Growth Metrics

Sanara MedTech (SMTI) Receivables - Net (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Receivables - Net for 15 consecutive years, with $12.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Receivables - Net rose 9.17% year-over-year to $12.1 million, compared with a TTM value of $12.1 million through Sep 2025, up 9.17%, and an annual FY2024 reading of $40566.0, down 99.52% over the prior year.
  • Receivables - Net was $12.1 million for Q3 2025 at Sanara MedTech, up from $9081.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $12.1 million in Q3 2025 and bottomed at $9081.0 in Q2 2025.
  • Average Receivables - Net over 5 years is $4.4 million, with a median of $2.9 million recorded in 2021.
  • The sharpest move saw Receivables - Net tumbled 99.52% in 2024, then surged 51467.26% in 2025.
  • Year by year, Receivables - Net stood at $2.9 million in 2021, then surged by 137.88% to $6.8 million in 2022, then grew by 24.53% to $8.5 million in 2023, then crashed by 99.52% to $40566.0 in 2024, then soared by 29693.04% to $12.1 million in 2025.
  • Business Quant data shows Receivables - Net for SMTI at $12.1 million in Q3 2025, $9081.0 in Q2 2025, and $11.9 million in Q1 2025.